Publication/Registration Details |
(1) 2024/8 Gaz on 2024-03-07 |
|
Designated Country Details
|
(1) AU under Protocol
(2) BR under Protocol
(3) CA under Protocol
(4) CH under Protocol
(5) EM under Protocol
(6) GB under Protocol
(7) IS under Protocol
(8) NO under Protocol
(9) NZ under Protocol
(10) US under Protocol
|
|
Goods & Services Limitation Details
|
Description
Class 05 -
Pharmaceutical preparations for the treatment of
hematological, autoimmune, inflammatory, respiratory, and
transplantation-related diseases and disorders;
pharmaceutical preparations for the treatment of generalized
myasthenia gravis; dietary supplements; pharmaceutical
preparations for the prevention of osteoporosis;
pharmaceutical preparations for the treatment of
osteoporosis; human vaccine preparations; pharmaceutical
preparations and compositions for the treatment and
prevention of cancer; pharmaceutical preparations for the
treatment of musculoskeletal disorders; pharmaceutical
preparations, namely, pharmaceutical preparations,
biological formulations, biological preparations, antibody
formulations and protein formulations for immunoregulation
and for treatment of immunologic disorders, autoimmune
diseases, inflammatory diseases, arthritis, cancer, tumor,
central nervous system disorders and metabolic diseases;
pharmaceutical preparations for the treatment of bone
fractures; pharmaceutical preparations for the prevention of
diseases of the musculoskeletal system; nutraceuticals for
medical purposes; pharmaceutical preparations for the
treatment of bone diseases; pharmaceutical preparations for
tumor treatment; preparations for treatment of cancer;
preparations for treatment of tumour diseases; preparations
for treatment of multiple myeloma; pharmaceutical
preparations for the treatment of skeletal diseases;
pharmaceutical preparations for the treatment of arthritis;
pharmaceutical preparations for the treatment of solid
cancer.
|